Kymera Therapeutics, Inc.
KYMR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815442
In the last 90 days, Kymera Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 276 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Kymera Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +15 vs. Q3 2021
- Shares held
- 43.5M
- +9.46M (+27.8%) vs. Q3 2021
- Total value
- $2.76B
- +$760.4M (+38.0%) vs. Q3 2021
- New holders
- 28
- 54 more added
- Sold out
- 13
- 28 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KYMR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 276 | $11.1B |
| Q1 2026 | 256 | $8.01B |
| Q4 2025 | 255 | $6.99B |
| Q3 2025 | 210 | $4.58B |
| Q2 2025 | 210 | $3.44B |
| Q1 2025 | 174 | $2.00B |
| Q4 2024 | 181 | $2.89B |
| Q3 2024 | 176 | $3.27B |
| Q2 2024 | 157 | $2.01B |
| Q1 2024 | 164 | $2.70B |
| Q4 2023 | 137 | $1.54B |
| Q3 2023 | 122 | $797.2M |
| Q2 2023 | 129 | $1.34B |
| Q1 2023 | 127 | $1.68B |
| Q4 2022 | 121 | $1.40B |
| Q3 2022 | 128 | $1.15B |
| Q2 2022 | 101 | $973.6M |
| Q1 2022 | 126 | $1.93B |
| Q4 2021 | 128 | $2.76B |
| Q3 2021 | 115 | $2.04B |
| Q2 2021 | 110 | $1.29B |
| Q1 2021 | 97 | $887.2M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Kymera Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 205,000 | $13.0M | 0.02% | −45,000−18.0% | Reduced |
| Wasatch Advisors Inc | 240,951 | $15.3M | 0.06% | −415−0.2% | Reduced |
| Charles Schwab Investment Management Inc | 248,534 | $15.8M | 0.00% | +5,309+2.2% | Added |
| UBS Asset Management Americas Inc | 266,051 | $16.9M | 0.01% | −238−0.1% | Reduced |
| Goldman Sachs Group Inc | 267,790 | $17.0M | 0.00% | +87,583+48.6% | Added |
| Clough Capital Partners L P | 271,000 | $17.2M | 1.16% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 318,667 | $20.2M | 2.40% | −40,593−11.3% | Reduced |
| Northern Trust Corp | 338,900 | $21.5M | 0.00% | +177+0.1% | Added |
| Candriam Luxembourg S.C.A. | 402,819 | $25.6M | 0.16% | +7,828+2.0% | Added |
| AJU IB Investment Co., Ltd. | 457,059 | $29.0M | 40.43% | −182,000−28.5% | Reduced |
| Bank of New York Mellon Corp | 530,718 | $33.7M | 0.01% | +29,838+6.0% | Added |
| Avoro Capital Advisors LLC | 550,000 | $34.9M | 0.59% | +94,250+20.7% | Added |
| Deer Management Co. LLC | 615,895 | $39.1M | 1.00% | +615,895 | New |
| Geode Capital Management, LLC | 620,042 | $39.4M | 0.00% | +20,172+3.4% | Added |
| Driehaus Capital Management LLC | 639,482 | $40.6M | 0.41% | +56,290+9.7% | Added |
| Avidity Partners Management LP | 670,000 | $42.5M | 0.90% | +155,500+30.2% | Added |
| Rock Springs Capital Management LP | 742,065 | $47.1M | 1.09% | +9,138+1.2% | Added |
| Artal Group S.A. | 1,000,000 | $63.5M | 1.87% | +600,000+150.0% | Added |
| State Street Corp | 1,641,762 | $104.2M | 0.00% | +201,986+14.0% | Added |
| FMR LLC | 2,347,527 | $149.0M | 0.01% | −8,280−0.4% | Reduced |
| Baker Bros. Advisors LP | 2,384,742 | $151.4M | 0.74% | 00.0% | Unchanged |
| Redmile Group, LLC | 2,587,730 | $164.3M | 3.74% | −205,978−7.4% | Reduced |
| Wellington Management Group LLP | 2,694,814 | $171.1M | 0.03% | +226,879+9.2% | Added |
| Vanguard Group Inc | 2,957,174 | $187.8M | 0.00% | +55,600+1.9% | Added |
| BVF Inc | 3,180,658 | $201.9M | 7.33% | 00.0% | Unchanged |
| BlackRock Inc. | 3,397,540 | $215.7M | 0.01% | +357,109+11.7% | Added |
| Price T Rowe Associates Inc | 3,550,528 | $225.4M | 0.02% | +317,331+9.8% | Added |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $436.5M | 40.09% | +6,875,698 | New |
| Bank of Montreal | 0 | $0 | 0.00% | −174,027−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −129,331−100.0% | Sold out |
| Asymmetry Capital Management, L.P. | 0 | $0 | 0.00% | −89,071−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −65,941−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −54,574−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −24,962−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −14,600−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,499−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −5,265−100.0% | Sold out |
| General Pension Society PZU Joint Stock Co | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −3,699−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −1,087−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Deer IX & Co. Ltd. | – | – | – | – | Not filed |
| First Mercantile Trust Co | – | – | – | – | Not filed |